Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Retained Earnings (2016 - 2025)

CV Sciences (CVSI) has disclosed Retained Earnings for 14 consecutive years, with -$87.9 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 1.1% to -$87.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$87.9 million through Dec 2025, down 1.1% year-over-year, with the annual reading at -$87.9 million for FY2025, 1.1% down from the prior year.
  • Retained Earnings hit -$87.9 million in Q4 2025 for CV Sciences, down from $47000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $53000.0 in Q2 2025 to a low of -$87.9 million in Q4 2025.
  • Historically, Retained Earnings has averaged -$64.3 million across 5 years, with a median of -$82.0 million in 2023.
  • Biggest YoY gain for Retained Earnings was 2750.0% in 2025; the steepest drop was 1741900.0% in 2025.
  • Year by year, Retained Earnings stood at -$79.5 million in 2021, then dropped by 7.42% to -$85.4 million in 2022, then grew by 0.92% to -$84.6 million in 2023, then decreased by 2.83% to -$87.0 million in 2024, then decreased by 1.1% to -$87.9 million in 2025.
  • Business Quant data shows Retained Earnings for CVSI at -$87.9 million in Q4 2025, $47000.0 in Q3 2025, and $53000.0 in Q2 2025.